Saavedra, C.;                     Vallejo, A.;                     Longo, F.;                     Serrano, J.J.;                     Fernández, M.;                     Gion, M.;                     López-Miranda, E.;                     MartÃnez-Jáñez, N.;                     Guerra, E.;                     Chamorro, J.;     
    et al.    Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers 2023, 15, 2000.
    https://doi.org/10.3390/cancers15072000
    AMA Style
    
                                Saavedra C,                                 Vallejo A,                                 Longo F,                                 Serrano JJ,                                 Fernández M,                                 Gion M,                                 López-Miranda E,                                 MartÃnez-Jáñez N,                                 Guerra E,                                 Chamorro J,         
        et al.        Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers. 2023; 15(7):2000.
        https://doi.org/10.3390/cancers15072000
    
    Chicago/Turabian Style
    
                                Saavedra, Cristina,                                 Alejandro Vallejo,                                 Federico Longo,                                 Juan José Serrano,                                 MarÃa Fernández,                                 MarÃa Gion,                                 Elena López-Miranda,                                 Noelia MartÃnez-Jáñez,                                 Eva Guerra,                                 Jesús Chamorro,         
         and et al.        2023. "Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors" Cancers 15, no. 7: 2000.
        https://doi.org/10.3390/cancers15072000
    
    APA Style
    
                                Saavedra, C.,                                 Vallejo, A.,                                 Longo, F.,                                 Serrano, J. J.,                                 Fernández, M.,                                 Gion, M.,                                 López-Miranda, E.,                                 MartÃnez-Jáñez, N.,                                 Guerra, E.,                                 Chamorro, J.,                                 Rosero, D.,                                 Velasco, H.,                                 MartÃn, A.,                                 Carrato, A.,                                 Casado, J. L.,                                 & Cortés, A.        
        
        (2023). Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers, 15(7), 2000.
        https://doi.org/10.3390/cancers15072000